| Robert Zhibo Yang, MD | |
|
7920 Cedar Ave S, Bloomington, MN 55425-1207 | |
| (608) 215-7030 | |
| Not Available |
| Full Name | Robert Zhibo Yang |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 12 Years |
| Location | 7920 Cedar Ave S, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497014740 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 62341 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allina United Hospital | Saint paul, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
Titan Medical Inc. announced today that it has signed an agreement with CAE Healthcare for various services related to the development of Titan's Amadeus® clinical-grade robotic surgery platform. Once completed, the platform could be used, not only to perform surgery at a distance, but also to train surgeons via simulation.
The World Health Organization (WHO) announced on October 26, 2009 that its 10 year study has shown a proven link between long term cell phone usage and increased risks in brain cancer and tumors. The ten year study headed by Dr. Elisabeth Cardis shows a 18% increase in brain tumor development with long term cell phone usage.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria on Monday will award nine companies for their efforts to fight the three diseases among employees, South Africa's Business Day reports. The coalition is a group of 220 companies worldwide that aim to address HIV, TB and malaria in the workplace.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Titan Medical Inc. announced today that it has signed an agreement with CAE Healthcare for various services related to the development of Titan's Amadeus® clinical-grade robotic surgery platform. Once completed, the platform could be used, not only to perform surgery at a distance, but also to train surgeons via simulation.
The World Health Organization (WHO) announced on October 26, 2009 that its 10 year study has shown a proven link between long term cell phone usage and increased risks in brain cancer and tumors. The ten year study headed by Dr. Elisabeth Cardis shows a 18% increase in brain tumor development with long term cell phone usage.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria on Monday will award nine companies for their efforts to fight the three diseases among employees, South Africa's Business Day reports. The coalition is a group of 220 companies worldwide that aim to address HIV, TB and malaria in the workplace.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Titan Medical Inc. announced today that it has signed an agreement with CAE Healthcare for various services related to the development of Titan's Amadeus® clinical-grade robotic surgery platform. Once completed, the platform could be used, not only to perform surgery at a distance, but also to train surgeons via simulation.
The World Health Organization (WHO) announced on October 26, 2009 that its 10 year study has shown a proven link between long term cell phone usage and increased risks in brain cancer and tumors. The ten year study headed by Dr. Elisabeth Cardis shows a 18% increase in brain tumor development with long term cell phone usage.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria on Monday will award nine companies for their efforts to fight the three diseases among employees, South Africa's Business Day reports. The coalition is a group of 220 companies worldwide that aim to address HIV, TB and malaria in the workplace.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Zhibo Yang, MD 420 Delaware St Se, Mmc 396, Minneapolis, MN 55455-0341 Ph: () - | Robert Zhibo Yang, MD 7920 Cedar Ave S, Bloomington, MN 55425-1207 Ph: (608) 215-7030 |
News Archive
Titan Medical Inc. announced today that it has signed an agreement with CAE Healthcare for various services related to the development of Titan's Amadeus® clinical-grade robotic surgery platform. Once completed, the platform could be used, not only to perform surgery at a distance, but also to train surgeons via simulation.
The World Health Organization (WHO) announced on October 26, 2009 that its 10 year study has shown a proven link between long term cell phone usage and increased risks in brain cancer and tumors. The ten year study headed by Dr. Elisabeth Cardis shows a 18% increase in brain tumor development with long term cell phone usage.
VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria on Monday will award nine companies for their efforts to fight the three diseases among employees, South Africa's Business Day reports. The coalition is a group of 220 companies worldwide that aim to address HIV, TB and malaria in the workplace.
› Verified 9 days ago
Jeffrey A Block, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-428-1800 Fax: 952-428-1723 |